Testing effectiveness (Phase 2)Ended earlyNCT01479465
What this trial is testing
Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
Who this might be right for
Colorectal Cancer
Gilead Sciences 266